CIR provides fiscal support for companies involved in R&D expenditure, and BioAgilytix’s European headquarters (registered as BioAgilytix Europe GmbH) has been granted this research tax credit based on our current research and technological development expenditures. We are excited to be able to provide our customers access to this tax break from the French Government.
Based on Art. 244 quarter B of the French Fiscal code, French clients can benefit from a tax credit of 30% of the total amount of R&D services eligible including salaries, social security contributions, amortization and depreciation allowances, operating costs, subcontracting, patents and monitoring. For further details on the CIR tax credit, click here.
Take advantage of the CIR tax credit with BioAgilytix’s Hamburg location as your CRO partner. Our bioanalytical lab services support all large molecule biotherapeutics research and development needs, as well as regulated work under GLP, GCP or GMP for pre-clinical and clinical studies and for manufacturing purposes.
Please do not hesitate to reach out with any questions about how the CIR tax credit can impact the work you do with BioAgilytix.
Services
Platforms
